MOLBIO vs VIKASLIFE: Stock Comparison
Head-to-head financial and trading comparison between Molbio Diagnostics Limited (MOLBIO) and Vikas Lifecare Limited (VIKASLIFE) in the Cross-Sector Peers sector.
MOLBIO
NSE: MOLBIOVIKASLIFE
NSE: VIKASLIFEKey Metrics Comparison Table
| Metric | MOLBIO | VIKASLIFE | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,438.60 | ₹1.19 | — |
| 1-Year Price Return | +38.1% | -19.05% | MOLBIO (57.15% higher) |
| 52-Week High | ₹1,544.70 | ₹1.52 | — |
| 52-Week Low | ₹1,036.65 | ₹1.18 | — |
| 30-Day Annualized Volatility | 95.93% | 26.82% | VIKASLIFE (Steadier) |
| 30-Day Average Daily Volume | 3,210,458 | 1,966,759 | MOLBIO (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MOLBIO and VIKASLIFE, which stock gave better returns over the last year?
MOLBIO has outperformed VIKASLIFE over the past 12 months with a gain of 38.1% compared to -19.05%.
Which stock is less volatile: MOLBIO or VIKASLIFE?
VIKASLIFE demonstrated lower price volatility (26.82% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MOLBIO vs VIKASLIFE?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MOLBIO and VIKASLIFE direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.